A Pharmaceuticals and Healthcare (API manufacturing) entity from India is looking to raise strategic funding.

Posted By - Investment Banker Posted date - 29/08/2020

BUSINESS BRIEF

Pharma company in the field of manufacturing APIs for Therapeutic drugs and Intermediates, R&D, Custom Synthesis is looking to raise funds to restart its operations. The firm has always focused on complicated chemistries and specialty products and manufactures various Therapeutic drugs including Anti-Parkinson, Anti-Ulcerative, Anti-Asthmatic, Anti Bacterial, etc. The firm has 2 units and to set up a second plant for which they took a loan from Bank but did not get the clearance due to the vested interest of the local government. It took 26 months to get clearance from the Local government. At the same time, an untimely separate state agitation happened and non-co-operation from banks led to the company becoming NPA. That's why sales are 0.

Proposal
Icon

Capital Requirement

INR 35 Cr

Icon

Justification

The firm has large domestic and international clients including Pfizer, Ranbaxy, Dr. Reddy, etc.

Icon

Funding Route

Private Equity, Strategic Investor

Icon

Extent Of Dilution

Upto 49 %

Icon

Share Holding Pattern

Promoter Group

100%

Non-Promoter Share Holder

0%

Icon

Reason For Raising Capital

Reduce Leverage

Icon

Entity is open for Investor keen on special situation/distress assets funding

Business Operation Information
Financial Information
2017 (in Cr) 2018 (in Cr) 2019 (in Cr) 2020 (in Cr)
Sales
N.D N.D N.D N.D
EBITDA
N.D N.D N.D N.D
PAT
N.D N.D N.D N.D
TOTAL DEBT
N.D N.D N.D N.D
Business Documents